Vascular Disease clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Sorry, accepting new patients by invitation only
Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.
Orange, California and other locations

Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension